End-of-day quote
Other stock markets
|
||
- SEK | - |
|
06-12 | Isofol Medical Starts Search for New CFO | MT |
06-12 | Isofol Medical AB Announces That Magnus Hurst, Chief Financial Officer to Leave the Company, Effective from September 2, 2024 | CI |
Business Summary
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Arfolitixorin
100.0
%
| 13 | 100.0 % | 1 | 100.0 % | -94.37% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Asia
100.0
%
| 13 | 100.0 % | 1 | 100.0 % | -94.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Petter Lindqvist
CEO | Chief Executive Officer | 72 | 01-08 |
Magnus Hurst
DFI | Director of Finance/CFO | 68 | 01-09 |
Roger Tell
CTO | Chief Tech/Sci/R&D Officer | 59 | 31/01/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lars Erik Lind
CHM | Chairman | 83 | - |
Sten Nilsson
BRD | Director/Board Member | 76 | 01-03 |
Alain Herrera
BRD | Director/Board Member | 74 | 31/12/17 |
79 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 161,515,440 | 107,964,057 ( 66.84 %) | 0 | 66.84 % |
Company contact information
Isofol Medical AB
Biotech Center Arvid Wallgrens Backe 20
413 46, Gothenburg
+46 3 17 97 22 80
http://www.isofol.se![address Isofol Medical AB (publ)](https://cdn.zonebourse.com/static/address/34912582.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+6.21% | 72.09B | |
+16.96% | 9.05B | |
-22.81% | 4.4B | |
+17.59% | 4.39B | |
+25.93% | 3.94B | |
+4.14% | 2.1B | |
+9.09% | 1.97B | |
-36.86% | 1.87B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- ISOFOL Stock
- Stock
- Company Isofol Medical AB (publ)